Small molecule-based therapy for Myocardial Infarction: Amifostine/Ethyol, a cytoprotective adjuvant, improves myocardial function after myocardial infarction via up-regulation of PNUTS, 14/November/2016, 10.55 am

Natural product-based anti-ageing therapy: Avicularin , found in Taxillus kaempferi, Rhododendron aureum, and Polygonum aviculare, among others, increases NMN levels, decreases age-associated weight gain, augments energy metabolism, improves physical activity and insulin sensitivity, promotes healthy lipid profile, and improves eye function via down regulation of its target gene, 13/November/2016, 1.13 pm
November 13, 2016
Natural product Immune enhancement therapy: (+)-Syringaresinol, isolated from Panax ginseng berry, and Prunus mume, among others, increases SOX2 expression and promotes innate immunity against bacterial infection via down-regulation of its target gene, 11/November/2016, 11.04 am
November 14, 2016
Show all

What they say: 

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Small molecule-based therapy for Myocardial Infarction: Amifostine/Ethyol, a cytoprotective adjuvant, improves myocardial function after myocardial infarction via  up-regulation of PNUTS


Significance:

Given that: (1)  cardiovascular disease is the leading cause of death worldwide; (2) in India, in 2004, 14.6 lakhs deaths (14% of total deaths) were due to ischemic heart disease; and (3) the global economic cost spent in the treatment of cardiovascular disease in 2011 was little more than 10 billion US dollars, there is an urgent need to find: (i)  a way to induce regeneration of adult cardiomyocytes that were lost in Myocardial patients; (ii) a cheaper alternative to the existing expensive drugs; and (iii) a side-effect-free drug.


From Research Findings to Therapeutic Opportunity: 

This study suggests a natural product-based cardiac regeneration therapy. Abelmoschus M. flower extract, by increasing the expression of its target gene, it may increase the expression of PNUTS. Thereby, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardiomyocyte survival/regeneration.

Amifostine.svg

Figure1. Amifostine/Ethyol may promote Cardiomyocyte survival and protect patients against Myocardial infarction via up-regulation of pro-survival protein PNUTS

Thus, by treating myocardial patients with Amifostine/Ethyolone may prevent ageing-associated (or, stress-associated) decline in cardiac function. Together, this study suggests that pharmacological formulations encompassing “Amifostine/Ethyol or its pharmacologically safer analogues”  may be used to improve cardiac function after myocardial infarction.  


Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Web:http://genomediscovery.org or http://newbioideas.com

To citeBoominathan, L.,  Small molecule-based therapy for Myocardial Infarction: Amifostine/Ethyol, a cytoprotective adjuvant, improves myocardial function after myocardial infarction via  up-regulation of PNUTS, 14/November/2016, 10.55 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org


Undisclosed information: How  Amifostine/Ethyol  increases the expression of PNUTS

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $100#

guaranteed-to-work1

Results guaranteed if not refunded

# Research cooperation

Comments are closed.